Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Drug Developer Exposes the Science Gap Behind the Peptide BoomSupplements

Drug Developer Exposes the Science Gap Behind the Peptide Boom

Peptides are everywhere in wellness circles, marketed for everything from injury recovery to anti-aging. But how much of the hype is backed by real science? In this episode of The Proof, Simon Hill speaks with Dr. Leigh Baxt, a drug development expert, who explains the critical difference between FDA-approved peptide medicines and the largely unregulated compounds being sold online and injected by thousands of people. She walks through how drug development actually works, why most promising compounds fail before reaching humans, and why animal or cell studies are nowhere near sufficient to establish safety. She also challenges the common assumption that 'natural' means safe, and offers a framework for evaluating peptide marketing claims critically. This is a timely reality check for anyone navigating the peptide landscape.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.